Shopping Cart
- Remove All
- Your shopping cart is currently empty
GSK1702934A, a selective TRPC3 agonist, modulates cardiac contractility and arrhythmogenesis through TRPC3 activation.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $69 | In Stock |
Description | GSK1702934A, a selective TRPC3 agonist, modulates cardiac contractility and arrhythmogenesis through TRPC3 activation. |
In vitro | GSK1702934A is capable of inducing TRPC3/6 currents in HEK293 cells transfected with recombinant human TRPC3/6 at EC50 values of 0.08 mM and 0.44 mM respectively, triggering transient, non-selective conductance and prolongation of action potentials in myocytes overexpressing TRPC3, and markedly enhancing NCX currents; however, these effects are not observed in wild-type myocytes[2]. |
Alias | GSK-1702934A, GSK 1702934A |
Molecular Weight | 395.52 |
Formula | C22H25N3O2S |
Cas No. | 924377-85-5 |
Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (202.27 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.